» Articles » PMID: 35197452

The Mechanism Underlying Extrapulmonary Complications of the Coronavirus Disease 2019 and Its Therapeutic Implication

Overview
Date 2022 Feb 24
PMID 35197452
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease 2019 (COVID-19) is a highly transmissible disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a major threat to global public health. Although COVID-19 primarily affects the respiratory system, causing severe pneumonia and acute respiratory distress syndrome in severe cases, it can also result in multiple extrapulmonary complications. The pathogenesis of extrapulmonary damage in patients with COVID-19 is probably multifactorial, involving both the direct effects of SARS-CoV-2 and the indirect mechanisms associated with the host inflammatory response. Recognition of features and pathogenesis of extrapulmonary complications has clinical implications for identifying disease progression and designing therapeutic strategies. This review provides an overview of the extrapulmonary complications of COVID-19 from immunological and pathophysiologic perspectives and focuses on the pathogenesis and potential therapeutic targets for the management of COVID-19.

Citing Articles

Caspase-8 activation regulates enterovirus D68 infection-induced inflammatory response and cell death.

Zhou Y, Zhang C, Zhang Y, Li F, Shen J Biosaf Health. 2025; 6(3):171-177.

PMID: 40078725 PMC: 11894973. DOI: 10.1016/j.bsheal.2024.03.003.


Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU.

Wang Z, Zhao L, Xie K BMC Infect Dis. 2025; 25(1):332.

PMID: 40065225 PMC: 11892215. DOI: 10.1186/s12879-025-10684-1.


Ultradiluted Prevents and Alleviates SARS-CoV-2 Spike Protein-Induced Lung Pathogenesis by Regulating Inflammatory Response and Apoptosis.

Roy A, Sarkar A, Roy A, Ghorai T, Nayak D, Kaushik S Diseases. 2025; 13(2).

PMID: 39997043 PMC: 11854276. DOI: 10.3390/diseases13020036.


Clinical Characteristics, Risk Factors, and Outcomes of Patients With Myocardial Injury due to Bloodstream Infections.

Chen Q, Xu P, Guan Z, Song F, Luo X, Zhang X Can J Infect Dis Med Microbiol. 2025; 2025:1795084.

PMID: 39949527 PMC: 11824389. DOI: 10.1155/cjid/1795084.


Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis.

Iqbal N, Khan H, Khalid A, Mahmood S, Nasir N, Khanum I Mol Med. 2025; 31(1):22.

PMID: 39849406 PMC: 11756069. DOI: 10.1186/s10020-024-00986-6.


References
1.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

2.
Zaim S, Chong J, Sankaranarayanan V, Harky A . COVID-19 and Multiorgan Response. Curr Probl Cardiol. 2020; 45(8):100618. PMC: 7187881. DOI: 10.1016/j.cpcardiol.2020.100618. View

3.
Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G . COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020; 51(6):613-628. PMC: 7533045. DOI: 10.1007/s10735-020-09915-3. View

4.
Nagele M, Haubner B, Tanner F, Ruschitzka F, Flammer A . Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020; 314:58-62. PMC: 7554490. DOI: 10.1016/j.atherosclerosis.2020.10.014. View

5.
Tang N, Li D, Wang X, Sun Z . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847. PMC: 7166509. DOI: 10.1111/jth.14768. View